AGP Executive Report
Last update: 9 hours agoAI & Health Innovation: A New Jersey teen, 17-year-old Edward Kang of Bergen County Academies, won major recognition for RetinaMind, an AI tool that screens for autism and ADHD using retinal images. Biotech Manufacturing: Cellares and Sonoma Biotherapeutics announced plans to automate manufacturing of an engineered Treg cell therapy on Cellares’ Cell Shuttle platform, aiming to streamline sensitive cell production. Public Health Watch: CDC-linked reporting says ER visits for tick bites are up more than 25% year over year, with Lyme season ramping up. NJ Energy & Solar: Black Bear Energy helped energize a 1.29 MW solar project in Elizabeth under New Jersey’s Community Solar Energy Program, with discounts for low- to middle-income subscribers. Supply Chain: A New Jersey-based supply-chain index says bottlenecks remain elevated into at least Q3 as manufacturers keep building buffer inventories. Regulation & Pharma: FDA selected seven companies, including Cellares, for a drug manufacturing pilot to speed technical feedback for new U.S. facilities. Tech Policy: Four states, including New Jersey, calculated potential penalties up to $1.4T against Meta over child addiction claims.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
